• DOI:10.1111/j.1365-2036.2010.04456.x
Corpus ID: 8485762

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study

@article{Goldberg2010ClinicalTT,
  title={Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study},
  author={M. Goldberg and Y. Li and J. F. Johanson and A. Mangel and M. Kitt and D. Beattie and K. Kersey and O. Dani{\'e}ls},
  journal={Alimentary Pharmacology & Therapeutics},
  year={2010},
  volume={32}
}

M. Goldberg, Y. Li, +5 authors O. Daniéls

Published 2010

Medicine

Alimentary Pharmacology & Therapeutics

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed

Aliment Pharmacol Ther 2010; 32: 1102–1112